NCT02005536View on ClinicalTrials.gov

Study of IMOVAX POLIO® Subcutaneous as a Booster Vaccine in Pre-school Age Children in Japan

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

October 31, 2014

Conditions
PoliomyelitisPolio
Interventions
BIOLOGICAL

IMOVAX POLIO®: Inactive Poliovirus Vaccine

0.5 mL, Subcutaneous

Trial Locations (4)

Unknown

Fukuoka

Hokkaido

Mie

Tokyo

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT02005536 - Study of IMOVAX POLIO® Subcutaneous as a Booster Vaccine in Pre-school Age Children in Japan | Biotech Hunter | Biotech Hunter